fam-trastuzumab deruxtecan-nxki

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:drug
gptkbp:activeIngredient	gptkb:trastuzumab_deruxtecan
gptkbp:approvalYear	2019
gptkbp:approvedBy	gptkb:FDA gptkb:EMA
gptkbp:ATCCode	gptkb:L01FG02
gptkbp:brand	gptkb:Enhertu
gptkbp:CASNumber	gptkb:2228327-56-2
gptkbp:coDeveloper	gptkb:AstraZeneca
gptkbp:developer	gptkb:Daiichi_Sankyo
gptkbp:drugClass	gptkb:antineoplastic_agent
gptkbp:form	lyophilized powder for solution for infusion
gptkbp:indication	gptkb:HER2-positive_breast_cancer gptkb:HER2-mutant_non-small_cell_lung_cancer HER2-positive gastric cancer
gptkbp:legalStatus	prescription only
gptkbp:mechanismOfAction	gptkb:monoclonal_antibody
gptkbp:pregnancyCategory	D (US)
gptkbp:routeOfAdministration	intravenous
gptkbp:sideEffect	gptkb:interstitial_lung_disease nausea vomiting fatigue neutropenia
gptkbp:target	HER2
gptkbp:UNII	6Y7T7T8A5B
gptkbp:usedFor	gptkb:non-small_cell_lung_cancer gptkb:cancer gastric cancer
gptkbp:bfsParent	gptkb:HER2/neu_receptor
gptkbp:bfsLayer	7
http://www.w3.org/2000/01/rdf-schema#label	fam-trastuzumab deruxtecan-nxki